LY3871801

DRUG4 trials

Sponsors

Eli Lilly and Company

Conditions

HealthyRheumatoid Arthritis

Phase 1

A Study of LY3871801 in Healthy Participants

CompletedNCT05222399

Eli Lilly and CompanyHealthy

Start: 2022-02-04End: 2022-03-11Updated: 2022-03-18

A Drug Interaction Study of LY3871801 in Healthy Participants

CompletedNCT05602675

Eli Lilly and CompanyHealthy

Start: 2022-11-02End: 2023-03-29Updated: 2023-04-18

A Study of LY3871801 in Healthy Asian and Non-Asian Participants

CompletedNCT05960851

Eli Lilly and CompanyHealthy

Start: 2023-08-09End: 2023-10-25Updated: 2024-01-10

Phase 2

An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis

CompletedNCT05848258

Eli Lilly and CompanyRheumatoid Arthritis

Start: 2023-05-23End: 2026-04-22Updated: 2026-05-22